z-logo
open-access-imgOpen Access
Docetaxel versus docetaxel plus cisplatin for non-small-cell lung cancer: a meta-analysis of randomized clinical trials
Author(s) -
Ang Li,
Zhijian Wei,
Han Ding,
Haoshuai Tang,
Hengxing Zhou,
Xue Yao,
Shiqing Feng
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.17071
Subject(s) - docetaxel , medicine , regimen , oncology , nausea , cochrane library , lung cancer , carboplatin , mucositis , randomized controlled trial , cisplatin , chemotherapy
To compare the activity, efficacy and toxicity of docetaxel versus docetaxel plus cisplatin in patients with non-small-cell lung cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom